Castle Biosciences Inc (CSTL)
$28.90 -$0.58 (-1.97%) 12:05 PM 12/12/24
NASDAQ | $USD | Diagnostics & ResearchStock Data
-
Market Cap
$873.55M -
Day's Range
$28.86 - $32.56 -
Volume
326,177 -
52 Week Low / High
$16.96 - $35.84 -
PE Ratio
148.52x -
PEG Ratio
- -
Dividend Frequency
-
CSTL's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 8
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $33.00
- Target Price
Company News
-
Study finds that using DecisionDx-SCC to guide patient selection for adjuvant radiation therapy (ART), identifying patients with cutaneous squamous cell carcinoma (SCC) who can safely forgo the treatment, could result in significant savings to the healthcare system FRIENDSWOOD, Texas, Jan...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$